Search research articles
Contact Us
Filters
Showing results (31-40 of 512) with videos related to
Page
of 52
Sort By:
Current Oncology Reports
|
August 27, 2025
Prostate Cancer Radioligand Therapy: PSMA and Beyond, Current Landscape and Future Directions
Eric H Bent, Michael J Morris
Otolaryngologic Clinics of North America
|
February 23, 2010
Vocal cord dysfunction, paradoxic vocal fold motion, or laryngomalacia? Our understanding requires an interdisciplinary approach
Kent L Christopher, Michael J Morris
Dialogues in Clinical Neuroscience
|
November 4, 2014
Role of DNA methylation and the DNA methyltransferases in learning and memory
Michael J Morris, Lisa M Monteggia
Frontiers in Veterinary Science
|
March 8, 2021
A Comparative Review of Autologous Conditioned Serum and Autologous Protein Solution for Treatment of Osteoarthritis in Horses
Livia Camargo Garbin, Michael J Morris
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 28, 2019
Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics
Kambiz Rahbar, Lisa Bodei, Michael J Morris
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 13, 2023
Looking at the Future of Prostate Cancer Treatment: A Conversation Between Michael Morris, Jeremie Calais, and Johannes Czernin
Michael J Morris, Jeremie Calais, Johannes Czernin
Seminars in Radiation Oncology
|
November 28, 2020
The Role of Theranostics in Prostate Cancer
Elisabeth O'Dwyer, Lisa Bodei, Michael J Morris
The Journal of Urology
|
July 24, 2007
Castration resistant, taxane naïve metastatic prostate cancer: current clinical approaches and future directions
Gretchen A Gignac, Michael J Morris, Maha Hussain
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 30, 2025
Concepts in Phase 1 Radiopharmaceutical Therapy Trial Designs: Lessons from the SNMMI Dose Optimization in Radiopharmaceutical Therapy Development Workshop
Michael J Morris, Thomas A Hope, Oliver Sartor
The New England Journal of Medicine
|
December 22, 2021
Lutetium-177-PSMA-617 for Prostate Cancer. Reply
Oliver Sartor, Michael J Morris, Bernd J Kraus
Page
of 52
Search research articles
Search
Showing results (31-40 of 512) with videos related to
Sort By:
Page
of 52
Current Oncology Reports
|
August 27, 2025
Prostate Cancer Radioligand Therapy: PSMA and Beyond, Current Landscape and Future Directions
Eric H Bent, Michael J Morris
Otolaryngologic Clinics of North America
|
February 23, 2010
Vocal cord dysfunction, paradoxic vocal fold motion, or laryngomalacia? Our understanding requires an interdisciplinary approach
Kent L Christopher, Michael J Morris
Dialogues in Clinical Neuroscience
|
November 4, 2014
Role of DNA methylation and the DNA methyltransferases in learning and memory
Michael J Morris, Lisa M Monteggia
Frontiers in Veterinary Science
|
March 8, 2021
A Comparative Review of Autologous Conditioned Serum and Autologous Protein Solution for Treatment of Osteoarthritis in Horses
Livia Camargo Garbin, Michael J Morris
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 28, 2019
Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics
Kambiz Rahbar, Lisa Bodei, Michael J Morris
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 13, 2023
Looking at the Future of Prostate Cancer Treatment: A Conversation Between Michael Morris, Jeremie Calais, and Johannes Czernin
Michael J Morris, Jeremie Calais, Johannes Czernin
Seminars in Radiation Oncology
|
November 28, 2020
The Role of Theranostics in Prostate Cancer
Elisabeth O'Dwyer, Lisa Bodei, Michael J Morris
The Journal of Urology
|
July 24, 2007
Castration resistant, taxane naïve metastatic prostate cancer: current clinical approaches and future directions
Gretchen A Gignac, Michael J Morris, Maha Hussain
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 30, 2025
Concepts in Phase 1 Radiopharmaceutical Therapy Trial Designs: Lessons from the SNMMI Dose Optimization in Radiopharmaceutical Therapy Development Workshop
Michael J Morris, Thomas A Hope, Oliver Sartor
The New England Journal of Medicine
|
December 22, 2021
Lutetium-177-PSMA-617 for Prostate Cancer. Reply
Oliver Sartor, Michael J Morris, Bernd J Kraus
Page
of 52